Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
15,776
+603
+4% +$70.6K 0.25% 28
2026
Q1
$1.83M Buy
15,173
+351
+2% +$40.5K 0.23% 25
2025
Q4
$1.56M Buy
14,822
+349
+2% +$32.8K 0.21% 31
2025
Q3
$1.21M Buy
14,473
+1,489
+11% +$123K 0.16% 42
2025
Q2
$1.03M Buy
12,984
+7,845
+153% +$624K 0.13% 42
2025
Q1
$461K Buy
5,139
+1,138
+28% +$106K 0.06% 71
2024
Q4
$398K Buy
4,001
+13
+0.3% +$1.34K 0.05% 71
2024
Q3
$433K Sell
3,988
-834
-17% -$99.1K 0.06% 68
2024
Q2
$597K Sell
4,822
-3,524
-42% -$454K 0.09% 54
2024
Q1
$1.1M Buy
8,346
+105
+1% +$12.9K 0.2% 26
2023
Q4
$898K Buy
8,241
+283
+4% +$29.4K 0.17% 30
2023
Q3
$819K Buy
7,958
+1,103
+16% +$119K 0.19% 29
2023
Q2
$791K Buy
6,855
+446
+7% +$50.6K 0.19% 30
2023
Q1
$682K Sell
6,409
-916
-13% -$98.9K 0.18% 31
2022
Q4
$813K Sell
7,325
-1,242
-14% -$127K 0.23% 25
2022
Q3
$738K Sell
8,567
-91
-1% -$8.12K 0.21% 27
2022
Q2
$789K Sell
8,658
-1,143
-12% -$101K 0.22% 32
2022
Q1
$804K Buy
9,801
+404
+4% +$31.9K 0.19% 30
2021
Q4
$720K Buy
9,397
+1,147
+14% +$91.4K 0.17% 34
2021
Q3
$620K Buy
8,250
+508
+7% +$38.6K 0.18% 43
2021
Q2
$602K Buy
7,742
+422
+6% +$31.4K 0.19% 42
2021
Q1
$538K Buy
7,320
+258
+4% +$19K 0.19% 36
2020
Q4
$551K Buy
7,062
+818
+13% +$62.6K 0.19% 36
2020
Q3
$494K Buy
6,244
+197
+3% +$15.4K 0.19% 40
2020
Q2
$446K Buy
6,047
+435
+8% +$32.7K 0.2% 40
2020
Q1
$409K Buy
+5,612
New +$441K 0.18% 41

Other funds holding MRK

Emerald Advisors's MRK Position: Q2 2026 in Review

Emerald Advisors increased its Merck (MRK) stake by 4% in Q2 2026, buying an estimated $70.6K and bringing the position to 15,776 shares worth $2.03M. The position accounts for 0.25% of the portfolio, ranked #28.

Emerald Advisors first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Emerald Advisors held 15,776 shares of Merck worth $2.03M as of Q2 2026.
  • Emerald Advisors bought 603 Merck shares in Q2 2026, an estimated $70.6K.
  • Merck made up 0.25% of Emerald Advisors's portfolio in Q2 2026, its #28 holding.
  • Emerald Advisors first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Emerald Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.